Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine doses in PCIA for cesarean section: analgesia and postpartum depression
ChiCTR2200060387Phase 4Recruiting
- Sponsor
- Nanjing Medical University Affiliated Nanjing Hospital
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in postpartum depression (PPD) and postoperative pain (3 arms), sponsored by Nanjing Medical University Affiliated Nanjing Hospital. Primary endpoints: Postoperative pain score, Postoperative sufentanil consumption and 4 more. Started Jun 2022; status: recruiting.
02
Drugs
esketamine
03
Conditions
postpartum depression (PPD)postoperative pain
Beyond the preview
Go deeper on ChiCTR2200060387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200060387.